Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

In an Imperfect World: Strategies for Psychiatric Clinical Trials

THE XTALKS BLOG

Studies involving psychiatry drugs may be uniquely challenging.

Tweetables from this article:

Tweet: Not all symptomatic improvement in mental disorders can necessarily be tied to the product under study. http://ctt.ec/lf2Zz+ Not all symptomatic improvement in mental disorders can necessarily be tied to the product under study.

Share this!

September 16, 2016 | by Megan Sims

In a perfect world, clinical drug trials draw conclusive results from objective observations. But we don’t live in that world, and we doubt you do, either.

Studies involving psychiatry drugs may be uniquely challenging. Ensuring that trial data accurately captures a compound’s safety and efficacy potential requires that you account for challenges inherent in working with a mentally ill population. Observing changes in the disease under study is partly a subjective process, and that creates risk of undue influence that the patient and/or investigator may not recognize.

To further complicate things, not all symptomatic improvement in mental disorders can necessarily be tied to the product under study. Some changes may result from unrelated factors whose therapeutic effect erodes the efficacy signal of a potential treatment.

On Tuesday, September 20, join two experts from Premier Research for a revealing look at these challenges. Krista Armstrong, Vice President of Strategic Development, and Susan Kozauer, Senior Medical Director, will present Conclusive Results: Strategies for Collecting Quality Data in Psychiatric Clinical Trials. The hour-long session, beginning at 11 a.m. Eastern time, will explore a range of factors that — if identified and mitigated early in the development process — can maximize the potential for conclusive study results. Look for a particular focus on:

  • Study design considerations
  • Site factors
  • Subject selection and eligibility
  • Data surveillance

The neuroscience experts at Premier Research have performed more than 150 neuroscience studies in just the past five years, their work touching more than 27,000 patients afflicted with all major central nervous system disorders. Register today for what is sure to be an informative presentation.



Keywords: Premier Research, Psychiatry, Clinical Trials


| NEXT ARTICLE | MORE BLOG POSTS | NEWS | VIDEOS | POLLS & QUIZZES | WEBINARS |

 

        Share this with your colleagues!




        READ THESE NEXT
        Top 5 Most Impactful Tweets in Drug Development During the Last Week

        June 19, 2017 - This week, we’ll be rounding up 5 of the most impactful tweets in drug development to keep you in the loop.


        Top 4 Most Impactful Tweets in Clinical Trials During the Last Week

        June 12, 2017 - This week, we’ll be rounding up 4 of the most impactful tweets in clinical trials to keep you in the loop.


        10 Things You Didn’t Know About Food and Beverage Fermentation

        June 6, 2017 - A whole host of health claims – from improved digestion to boosted immunity – have been made regarding consumption of fermented foods.

        LEAVE A COMMENT
         
          
        THE XTALKS VITALS WEBINAR PRODUCTION TIPS BLOG

        6 Tips to Overcome Nervousness When Speaking in a Webinar

        REGISTER FOR THESE WEBINARS

        Serialized? Yes. But are Products Still Being Diverted?


        Quantitative Protein Profiling in FFPE to Characterize Toxicities Associated with Immune Checkpoint Inhibitors


        Are You Choosing the Right Model? A Guide to Selecting Your Next Immuno-Oncology Model


        Imaging-based Subtypes of Pancreatic Cancer


        Copyright © 2016-2017 Honeycomb Worldwide Inc.